Quaker Chemical Corporation

10/22/2026 | Press release | Distributed by Public on 10/22/2026 14:37

Management Change/Compensation (Form 8-K)

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On October 16, 2026, Quaker Chemical Corporation (the "Company") appointed Neil Daniels, age 61, as Vice President, Chief Accounting Officer, effective upon his anticipated employment start date of November 16, 2026. In that role, Mr. Daniels will serve as the Company's principal accounting officer. Mr. Daniels previously worked as a consultant to Teleflex Inc., having rejoined the organization in February 2025 after previously serving as Vice President, Finance and Assistant Corporate Controller for Teleflex Inc. for over ten years from 2012 through 2022. Prior to rejoining Teleflex, Mr. Daniels served as Vice President and Global Controller at Nouryon from May 2024 to February 2025. Before that, he served as Vice President and Corporate Controller at Emergent BioSolutions from November 2022 through May 2024. Mr. Daniels is a Certified Public Accountant and has a Bachelor of Business Administration in Accounting.
On October 16, 2026, the Company and Mr. Daniels entered into an Employment Agreement (the "Employment Agreement") that provides for an annual base salary of $370,000 and eligibility to participate in the Company's Annual Incentive Plan with a target award percentage of 35% of his base salary for 2027, dependent on the Company's financial results and other objectives. Mr. Daniels is also eligible to participate in the Company's Long-Term Performance Incentive Plan with an annual grant of time-based restricted stock units and target performance stock units having an aggregate value of $110,000. Mr. Daniels will also be provided with a cash sign-on bonus in the amount of $175,000. Mr. Daniels will be required to repay his bonus to the Company if he terminates his employment under certain circumstances as detailed in his Employment Agreement. Mr. Daniels will also be entitled to medical, dental, and other benefits as are made generally available by the Company to its full-time U.S. employees.
Pursuant to Mr. Daniels's Employment Agreement, he is also subject to non-disclosure, non-competition, and non-solicitation covenants similar to those of other Company officers. The foregoing summary of the Employment Agreement does not purport to be a complete description of all of the terms and conditions of the document, and is qualified in its entirety by reference to the full text of the Employment Agreement, which is filed as an exhibit to this Current Report on Form 8-K.
There are no arrangements or understandings between Mr. Daniels and any other person pursuant to which he was selected as an officer, there are no family relationships between Mr. Daniels and any director or executive officer of the Company, and he has no direct or indirect material interest in any existing or currently proposed transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.
In connection with Mr. Daniels's appointment, Thomas Coler will cease to serve as the Company's principal accounting officer, a role he has held since July 22, 2026. Mr. Coler will continue to serve as Executive Vice President, Chief Financial Officer.
Quaker Chemical Corporation published this content on October 22, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on October 22, 2026 at 20:37 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]